Activated CD4+CD25+ T cells selectively kill B lymphocytes

Blood

Volumn 107, Issue 10, 2006, Pages 3925-3932

  Zhao, Dong Mei ^a   Thornton, Angela M ^a   DiPaolo, Richard J ^a   Shevach, Ethan M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; FAS LIGAND; GRANZYME B; INTERLEUKIN 2 RECEPTOR ALPHA; PERFORIN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CELL CONTACT; CELL CULTURE; CELL FUNCTION; CELL PROLIFERATION; ENZYME REGULATION; FEMALE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN INTERACTION; SUPPRESSOR CELL; T LYMPHOCYTE; UPREGULATION;

EID: 33646567156     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-11-4502     Document Type: Article

References (43)

1. Mason D, Powrie F. Control of immune pathology by regulatory T cells. Curr Opin Immunol.1998;10:649-655.
2. Shevach EM. Regulatory T cells in autoimmunity. Annu Rev Immunol. 2000;18:423-429.
3. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell. 2000;101:455-458.
4. + cells: a naturally occurring population of regulatory T cells. Blood. 2001;98:2736-2744.
5. + T cells: a common basis between tumor immunity and autoimmunity. J Immunol. 1999;163:5211-5218.
6. + T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol. 2002;32:1282-1291.
7. + regulatory T cells control Leishmania major persistence and immunity. Nature. 2002;420:502-507.
8. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998;188:287-296.
9. + immunoregulatory T cells is antigen nonspecific. J Immunol. 2000;164:183-190.
10. + immunoregulatory cells. J Immunol. 2001;167:1137-1140.
11. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med. 1999;190:995-1004.
12. + T cells. J Exp Med. 1996;183:2669-2674.
13. - thymocytes. J Exp Med. 1999;189:279-288.
14. + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol. 2005;174:1783-1786.
15. + T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med. 1998;188:1883-1894.
16. McHugh RS, Shevach EM, Margulies DH, Natarajan K. A T cell receptor transgenic model of severe spontaneous organ-specific autoimmunity. Eur J Immunol. 2001;31:2094-2103.
17. Curotto de Lafaille MA, Muriglan S, Sunshine MJ, et al. Hyper immunoglobulin E response in mice with monoclonal populations of B and T lymphocytes. J Exp Med. 2001;194:1349-1359.
18. Seo SJ, Fields ML, Buckler JL, et al. The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity. 2002;16:535-546.
19. Grossman WJ, Verbsky JW, Barchet W, et al. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity. 2004;21:589-601.
20. + single positive cells with a class II major histocompatibility complex-restricted receptor. J Exp Med. 1994;180:25-34.
21. Wherry EJ, Teichgraber V, Becker TC, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol. 2003;4:225-234.
22. Caramalho I, Lopes-Carvalho T, Ostler D, et al. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med. 2003;197:403-411.
23. Kagi D, Ledermann B, Burki K, Zinkernagel RM, Hengartner H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol. 1996;14:207-232.
24. Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol. 2002;20:323-370.
25. Nagata S. Apoptosis by death factor. Cell. 1997;88:355-365.
26. Berke G. The binding and lysis of target cells by cytotoxic T lymphocytes: molecular and cellular aspects. Annu Rev Immunol. 1994;12:735-773.
27. Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol. 1991;9:243-269.
28. Alderson MR, Tough TW, Davis-Smith T, et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med. 1995;181:71-77.
29. Lynch DH, Watson ML, Alderson MR, et al. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity. 1994;1:131-136.
30. Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand. Cell. 1994;76:969-976.
31. + T cells by a flow cytometric assay for degranulation. J Immunol Methods. 2003;281:65-78.
32. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods. 2004;294:15-22.
33. Kannan K, Stewart RM, Bounds W, et al. Lysosome-associated membrane proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) are activation-dependent cell surface glycoproteins in human peripheral blood mononuclear cells which mediate cell adhesion to vascular endothelium. Cell Immunol. 1996;171:10-19.
34. Bossi G, Griffiths GM. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat Med. 1999;5:90-96.
35. Odake S, Kam CM, Narasimhan L, et al. Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins. Biochemistry. 1991;30:2217-2227.
36. Song Q, Burrows SR, Smith G, et al. Interleukin-1β-converting enzyme-like protease cleaves DNA-dependent protein kinase in cytotoxic T cell killing. J Exp Med. 1996;184:619-626.
37. Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG. B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol. 2001;2:1126-1132.
38. + regulatory T cells. J Immunol. 2005;175:4180-4183.
39. + T cell suppressor function. J Immunol. 2004;172:6519-6523.
40. Ashwell JD, Cunningham RE, Noguchi PD, Hernandez D. Cell growth cycle block of T cell hybridomas upon activation with antigen. J Exp Med. 1987;165:173-194.
41. Motyka B, Korbutt G, Pinkoski MJ, et al. Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell. 2000;103:491-500.
42. Pinkoski MJ, Hobman M, Heibein JA, et al. Entry and trafficking of granzyme B in target cells during granzyme B-perforin-mediated apoptosis. Blood. 1998;92:1044-1054.
43. Choy JC, Hung VH, Hunter AL, et al. Granzyme B induces smooth muscle cell apoptosis in the absence of perforin involvement of extracellular matrix degradation. Arterioscler Thromb Vasc Biol. 2004;24:2245-2250.